CCR2 and brain neoplasm: In addition, we also found that CCR2b.B7-H3.28 CAR-T cells exhibited superior antitumor activity in a second NSCLC brain tumor model, in which the mice were engrafted i.c. with FFluc-H520 tumor cell.